23
total announcements
539230.BO · 15 min delayed
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd publishes un-audited financial results for the quarter and half year ended September 30, 2026, in compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has submitted its unaudited standalone financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has announced the outcome of its board meeting held on November 4, 2026, where the board considered and approved the unaudited financial results for the quarter and half year ended September 30, 2026, and noted the limited review report from the statutory auditor.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has scheduled a Board Meeting on 04/11/2026 to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has approved the allotment of 1,00,00,000 unlisted Non-Convertible Redeemable Preference Shares (NCRPS) on a private placement basis under the First Tranche.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has approved the allotment of 1,00,00,000 unlisted Non-Convertible Redeemable Preference Shares (NCRPS) under the First Tranche on a private placement basis.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has scheduled a board meeting on 28/10/2026 to consider the allotment of unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on a private placement basis.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018, regarding dematerialization and rematerialization of securities during the quarter ended September 30, 2026.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has submitted the e-voting and scrutinizer's report for its 40th Annual General Meeting held on September 30, 2026. All resolutions were approved by the members, including the appointment of a director and the adoption of financial statements for the year ended March 31, 2026.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd held its 40th Annual General Meeting on September 30, 2026, where members adopted the financial statements for the year ended March 31, 2026, and reappointed a director. The meeting also approved related party transactions with group companies and promoters.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd held its 40th Annual General Meeting on September 30, 2026, where the financial statements for the year ended March 31, 2026, were adopted, and a director, Mr. Rushabh Mehta, was reappointed. The meeting also approved related party transactions with group companies and promoters.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd held its 40th Annual General Meeting on September 30, 2026, where the financial statements for the year ended March 31, 2026, were adopted, and a director, Mr. Rushabh Mehta, was reappointed. The company also approved related party transactions with group companies and promoters.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has announced the closure of its trading window for insiders from October 1, 2026, until 48 hours after the announcement of its un-audited financial results for the half year ended September 30, 2026.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has published a newspaper advertisement for its 40th Annual General Meeting (AGM) to be held on September 30, 2026, at its registered office. The company has also provided remote e-voting and e-voting facilities to its members.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has sent a letter to shareholders who have not registered their email address, providing a weblink to the Annual Report for FY 2025-26. The company has also announced its 40th Annual General Meeting (AGM) on September 30, 2026, and reminded shareholders to update their KYC details and dematerialize physical securities.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has announced its Annual Report for FY 2025-26, along with the notice for its 40th Annual General Meeting (AGM) to be held on September 30, 2026. The AGM will consider the financial statements for FY 2025-26, reappointment of a director, and approval of related party transactions.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has announced the 40th Annual General Meeting (AGM) to be held on September 30, 2026, at 11:00 am. The meeting will consider the reappointment of Mr. Rushabh Mehta as director, approval of related party transactions, and increase in authorized share capital.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has published unaudited financial results for the quarter ended 30th June 2026 in compliance with SEBI regulations.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has submitted a corrigendum to rectify a typographical error in the book closure date and Benpose date for the 40th Annual General Meeting. The corrected dates are 24/09/2026 to 30/09/2026 for share transfer book closure and 28/08/2026 for Benpose Date.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026, and approved several matters, including increasing authorized share capital, issuing unlisted non-convertible redeemable preference shares, and fixing the date for the 40th Annual General Meeting.